# FRED HUTCHINSON CANCER CENTER: Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | FRED HUTCHINSON CANCER CENTER |
| Location | SEATTLE, WA |
| Project | Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs |
| Project number | 3U19AI174242-04S1 |
| Mechanism | U19 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $2,002,573 |
| Awarded | 2026-09-17 |
| Project period | 2023-01-30 to 2027-12-31 |
| UEI | TJFZLPP6NYL6 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11375199). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.